Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Colorectal Adenocarcinoma × Fluoxetine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Anxiety Disorders 2 Weight Loss 1 Recurrence 1 Lung Neoplasms 1 Glioma 1 Fatigue 1 Depression 1 Colorectal Adenocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Cachexia 1 Brain Neoplasms 1 Advanced Cancer 1 Adenocarcinoma of Lung 1

Interventions

Radiotherapy 1 Pharmaceutical Preparations 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 HMPL-013 1 Fluoxetine 1 Fluorouracil 1 Cholecalciferol 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06225011 2025-05-13

Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer

Jonsson Comprehensive Cancer Center

Phase 1 Recruiting

Gastrointestinal

Colorectal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡